GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing the brunt of the layoffs, according to local news reports. Citing information from the Canadian Union of Public Employees, the Canadian Press reports that GSK is planning to cut 60 skilled positions in Quebec City, where it currently employs around 700 staff. "We were open to consider constructive solutions to minimise job losses and at the same time meet the financial goals of our employer," commented Dominic Morin, president of the GSK employees' union chapter at CUPE. "They chose the easy way out: cutting jobs."
